To probe the mechanism of the Hsp90 chaperone that is required for the maturation of many signaling proteins in eukaryotes, we analyzed the effects of all individual amino acid changes in the ATPase domain on yeast growth rate. The sensitivity of a position to mutation was strongly influenced by proximity to the phosphates of ATP, indicating that ATPase-driven conformational changes impose stringent physical constraints on Hsp90. To investigate how these constraints may vary for different clients, we performed biochemical analyses on a panel of Hsp90 mutants spanning the full range of observed fitness effects. We observed distinct effects of nine Hsp90 mutations on activation of v-src and glucocorticoid receptor (GR), indicating that differ...
The Hsp90 molecular chaperone catalyses the final activation step of many of the most important regu...
The Hsp90 chaperone is responsible for the activation and maturation of an eclectic set of proteins....
AbstractHsp90 inhibitors are currently tested in clinical trials as anticancer agents. We investigat...
SummaryTo probe the mechanism of the Hsp90 chaperone that is required for the maturation of many sig...
To probe the mechanism of the Hsp90 chaperone that is required for the maturation of many signaling ...
The mechanism of client protein activation by Hsp90 is enigmatic, and it is uncertain whether Hsp90 ...
The mechanism of client protein activation by Hsp90 is enigmatic, and it is uncertain whether Hsp90 ...
The Heat Shock Protein 90 (Hsp90) is an essential and highly conserved chaperone that facilitates th...
The heat shock protein 90 (Hsp90) family of heat shock proteins is an abundantly expressed and highl...
The Hsp90 chaperone is required for the maturation of signal transduction clients, including many ki...
International audienceHeat shock protein 90 (Hsp90) is a highly conserved ATP-dependent molecular ch...
Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone responsible for the activatio...
In natural systems, selection acts on both protein sequence and expression level, but it is unclear ...
Heat shock protein 90 (Hsp90) is an abundant molecular chaperone, involved in the folding and activa...
Among heat shock proteins, Hsp90 is unusual because it is not required for the proper folding of mos...
The Hsp90 molecular chaperone catalyses the final activation step of many of the most important regu...
The Hsp90 chaperone is responsible for the activation and maturation of an eclectic set of proteins....
AbstractHsp90 inhibitors are currently tested in clinical trials as anticancer agents. We investigat...
SummaryTo probe the mechanism of the Hsp90 chaperone that is required for the maturation of many sig...
To probe the mechanism of the Hsp90 chaperone that is required for the maturation of many signaling ...
The mechanism of client protein activation by Hsp90 is enigmatic, and it is uncertain whether Hsp90 ...
The mechanism of client protein activation by Hsp90 is enigmatic, and it is uncertain whether Hsp90 ...
The Heat Shock Protein 90 (Hsp90) is an essential and highly conserved chaperone that facilitates th...
The heat shock protein 90 (Hsp90) family of heat shock proteins is an abundantly expressed and highl...
The Hsp90 chaperone is required for the maturation of signal transduction clients, including many ki...
International audienceHeat shock protein 90 (Hsp90) is a highly conserved ATP-dependent molecular ch...
Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone responsible for the activatio...
In natural systems, selection acts on both protein sequence and expression level, but it is unclear ...
Heat shock protein 90 (Hsp90) is an abundant molecular chaperone, involved in the folding and activa...
Among heat shock proteins, Hsp90 is unusual because it is not required for the proper folding of mos...
The Hsp90 molecular chaperone catalyses the final activation step of many of the most important regu...
The Hsp90 chaperone is responsible for the activation and maturation of an eclectic set of proteins....
AbstractHsp90 inhibitors are currently tested in clinical trials as anticancer agents. We investigat...